Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Saprochaete clavata Infections in Patients Undergoing Treatment for Hematological Malignancies: A Report of a Monocentric Outbreak and Review of the Literature.

Stanzani M, Cricca M, Sassi C, Sutto E, De Cicco G, Bonifazi F, Bertuzzi C, Bacci F, Paolini S, Cavo M, Lewis RE.

Mycoses. 2019 Jul 31. doi: 10.1111/myc.12978. [Epub ahead of print]

PMID:
31365161
2.

Beyond biomarkers: How enhanced CT imaging can improve the diagnostic-driven management of invasive mould disease.

Stanzani M, Sassi C, Battista G, Lewis RE.

Med Mycol. 2019 Jun 1;57(Supplement_3):S274-S286. doi: 10.1093/mmy/myy125.

PMID:
31292659
3.

Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies.

Stanzani M, Vianelli N, Cavo M, Kontoyiannis DP, Lewis RE.

J Infect. 2019 Jun;78(6):484-490. doi: 10.1016/j.jinf.2019.04.002. Epub 2019 Apr 8.

PMID:
30974130
4.

Development and Applications of Prognostic Risk Models in the Management of Invasive Mold Disease.

Stanzani M, Lewis RE.

J Fungi (Basel). 2018 Dec 19;4(4). pii: E141. doi: 10.3390/jof4040141. Review.

5.

Acute Invasive Fungal Rhinosinusitis in Immunocompromised Patients: Role of an Early Diagnosis.

Fernandez IJ, Crocetta FM, Demattè M, Farneti P, Stanzani M, Lewis RE, Fornaciari M, Pasquini E, Sciarretta V.

Otolaryngol Head Neck Surg. 2018 Aug;159(2):386-393. doi: 10.1177/0194599818765744. Epub 2018 Mar 20.

PMID:
29558254
6.

The utility of contrast-enhanced hypodense sign for the diagnosis of pulmonary invasive mould disease in patients with haematological malignancies.

Sassi C, Stanzani M, Lewis RE, Facchini G, Bazzocchi A, Cavo M, Battista G.

Br J Radiol. 2018 Feb;91(1083):20170220. doi: 10.1259/bjr.20170220. Epub 2018 Jan 10.

7.

Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.

Rizzello I, Castagnetti F, Toschi PG, Bertaccini P, Primavera L, Paolucci M, Faccioli L, Spinardi L, Lewis RE, Cavo M, Stanzani M.

Mycoses. 2018 Jan;61(1):53-60. doi: 10.1111/myc.12697. Epub 2017 Sep 22. Review.

PMID:
28872724
8.

Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report.

Pagano L, Dragonetti G, Cattaneo C, Marchesi F, Veggia B, Busca A, Candoni A, Prezioso L, Criscuolo M, Cesaro S, Delia M, Fanci R, Stanzani M, Ferrari A, Martino B, Melillo L, Nadali G, Simonetti E, Ballanti S, Picardi M, Castagnola C, Decembrino N, Gazzola M, Fracchiolla NS, Mancini V, Nosari A, Principe MID, Aversa F, Tumbarello M; SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia).

Haematologica. 2017 Oct;102(10):e407-e410. doi: 10.3324/haematol.2017.172536. Epub 2017 Jul 20. No abstract available.

9.

Retrospective Cohort Analysis of Liposomal Amphotericin B Nephrotoxicity in Patients with Hematological Malignancies.

Stanzani M, Vianelli N, Cavo M, Maritati A, Morotti M, Lewis RE.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e02651-16. doi: 10.1128/AAC.02651-16. Print 2017 Sep.

10.

Radiologic findings of Fusarium pneumonia in neutropenic patients.

Sassi C, Stanzani M, Lewis RE, Vianelli N, Tarsi A, Poerio A, Cavo M, Battista G.

Mycoses. 2017 Feb;60(2):73-78. doi: 10.1111/myc.12538. Epub 2016 Jul 29.

PMID:
27470138
11.

ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy.

D'Angelo R, Rinaldi R, Carelli V, Boschetti E, Caporali L, Capristo M, Casali C, Cenacchi G, Gramegna LL, Lodi R, Pinna AD, Pironi L, Stanzani M, Tonon C, D'Alessandro R, De Giorgio R.

Neurol Sci. 2016 Jul;37(7):1149-51. doi: 10.1007/s10072-016-2552-7. Epub 2016 Mar 23.

PMID:
27007276
12.

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes.

Finelli C, Follo MY, Stanzani M, Parisi S, Clissa C, Mongiorgi S, Barraco M, Cocco L.

Curr Pharm Des. 2016;22(16):2349-57.

PMID:
26960675
13.

An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes.

Cocco L, Finelli C, Mongiorgi S, Clissa C, Russo D, Bosi C, Quaranta M, Malagola M, Parisi S, Stanzani M, Ramazzotti G, Mariani GA, Billi AM, Manzoli L, Follo MY.

J Leukoc Biol. 2015 Nov;98(5):769-80. doi: 10.1189/jlb.2MA1114-541R. Epub 2015 May 14.

PMID:
25977289
14.

Computerized tomographic pulmonary angiography discriminates invasive mould disease of the lung from lymphoma.

Sassi C, Stanzani M, Lewis RE.

Br J Haematol. 2015 May;169(4):462. doi: 10.1111/bjh.13356. Epub 2015 Mar 29. No abstract available.

PMID:
25818621
15.

High resolution computed tomography angiography improves the radiographic diagnosis of invasive mold disease in patients with hematological malignancies.

Stanzani M, Sassi C, Lewis RE, Tolomelli G, Bazzocchi A, Cavo M, Vianelli N, Battista G.

Clin Infect Dis. 2015 Jun 1;60(11):1603-10. doi: 10.1093/cid/civ154. Epub 2015 Feb 25.

PMID:
25722200
16.

Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant.

Lauro A, Stanzani M, Finelli C, Zanfi C, Morelli MC, Pasqualini E, Dazzi A, Ravaioli M, Di Simone M, Giudice V, Pironi L, Pinna AD.

Case Rep Transplant. 2014;2014:262953. doi: 10.1155/2014/262953. Epub 2014 Aug 11.

17.

Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study.

Mancini N, Sambri V, Corti C, Ghidoli N, Tolomelli G, Paolucci M, Clerici D, Carletti S, Greco R, Tassara M, Pizzorno B, Zaniolo O, Povero M, Pradelli L, Burioni R, Stanzani M, Landini MP, Ciceri F, Clementi M.

Expert Rev Mol Diagn. 2014 Jun;14(5):623-32. doi: 10.1586/14737159.2014.916212.

PMID:
24844138
18.

[The role of iron metabolism in myelodysplastic syndromes].

Finelli C, Clissa C, Stanzani M.

Recenti Prog Med. 2014 Mar;105(3):123-6. doi: 10.1701/1434.15874. Italian.

PMID:
24675455
19.

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, Pecoraro C, Guidi S, Iori AP, Montante B, Chiusolo P, Lanino E, Carella AM, Zucchetti E, Bruno B, Irrera G, Patriarca F, Baronciani D, Musso M, Prete A, Risitano AM, Russo D, Mordini N, Pastore D, Vacca A, Onida F, Falcioni S, Pisapia G, Milone G, Vallisa D, Olivieri A, Bonini A, Castagnola E, Sica S, Majolino I, Bosi A, Busca A, Arcese W, Bandini G, Bacigalupo A, Rambaldi A, Locasciulli A.

Biol Blood Marrow Transplant. 2014 Jun;20(6):872-80. doi: 10.1016/j.bbmt.2014.03.004. Epub 2014 Mar 14.

20.

A risk prediction score for invasive mold disease in patients with hematological malignancies.

Stanzani M, Lewis RE, Fiacchini M, Ricci P, Tumietto F, Viale P, Ambretti S, Baccarani M, Cavo M, Vianelli N.

PLoS One. 2013 Sep 26;8(9):e75531. doi: 10.1371/journal.pone.0075531. eCollection 2013.

21.

Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.

Arpinati M, Tolomelli G, Bochicchio MT, Castagnetti F, Amabile M, Bandini G, Bonifazi F, Stanzani M, Rosti G, Martinelli G, Baccarani M.

Biol Blood Marrow Transplant. 2013 May;19(5):735-40. doi: 10.1016/j.bbmt.2013.01.007. Epub 2013 Jan 17.

22.

Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients.

Paolucci M, Stanzani M, Melchionda F, Tolomelli G, Castellani G, Landini MP, Varani S, Lewis RE, Sambri V.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):130-4. doi: 10.1016/j.diagmicrobio.2012.10.012. Epub 2012 Nov 22.

PMID:
23177222
23.

Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients.

Broccoli A, Stanzani M, Bandini G, Bonifazi F, Stefoni V, Pellegrini C, Derenzini E, Gandolfi L, Quirini F, Argnani L, Tschon M, Casadei B, Baccarani M, Zinzani PL.

Leuk Lymphoma. 2013 Aug;54(8):1791-3. doi: 10.3109/10428194.2012.749470. Epub 2012 Dec 22. No abstract available.

PMID:
23153229
24.

Hairy cell leukemia: allogeneic transplantation could be an optimal option in selected patients.

Zinzani PL, Bonifazi F, Pellegrini C, Casadei B, Argnani L, Motta MR, Dan E, Stanzani M, Arpinati M, Bandini G.

Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):287-9. doi: 10.1016/j.clml.2012.05.001. Epub 2012 May 24. No abstract available.

PMID:
22633165
25.

Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies.

Stanzani M, Battista G, Sassi C, Lewis RE, Tolomelli G, Clissa C, Femia R, Bazzocchi A, Tumietto F, Viale P, Ambretti S, Baccarani M, Vianelli N.

Clin Infect Dis. 2012 Mar 1;54(5):610-6. doi: 10.1093/cid/cir861. Epub 2012 Feb 4.

PMID:
22173235
26.

Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis.

Bonifazi F, Bandini G, Arpinati M, Tolomelli G, Stanzani M, Motta MR, Rizzi S, Giudice V, Dan E, Massari E, Tazzari P, Bontadini A, Pagliaro P, Baccarani M.

Bone Marrow Transplant. 2012 Aug;47(8):1105-11. doi: 10.1038/bmt.2011.225. Epub 2011 Nov 21.

PMID:
22101198
27.

Systemic infections caused by Escherichia coli in a neutropenic patient with multiple TLR gene polymorphisms abolished by stem-cell transplantation.

Rossini G, Stanzani M, Baccarani M, Tolomelli G, Landini MP, Sambri V, Varani S.

Transplantation. 2011 Apr 15;91(7):e49-51. doi: 10.1097/TP.0b013e31820cfdad. No abstract available.

PMID:
21436650
28.

Sinonasal risk factors for the development of invasive fungal sinusitis in hematological patients: Are they important?

Fernandez IJ, Stanzani M, Tolomelli G, Pasquini E, Vianelli N, Baccarani M, Sciarretta V.

Allergy Rhinol (Providence). 2011 Jan;2(1):6-11. doi: 10.2500/ar.2011.2.0009.

29.

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.

Pagano L, Caira M, Candoni A, Offidani M, Martino B, Specchia G, Pastore D, Stanzani M, Cattaneo C, Fanci R, Caramatti C, Rossini F, Luppi M, Potenza L, Ferrara F, Mitra ME, Fadda RM, Invernizzi R, Aloisi T, Picardi M, Bonini A, Vacca A, Chierichini A, Melillo L, de Waure C, Fianchi L, Riva M, Leone G, Aversa F, Nosari A.

Haematologica. 2010 Apr;95(4):644-50. doi: 10.3324/haematol.2009.012054. Epub 2009 Oct 22.

30.

Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology).

Pagano L, Valentini CG, Posteraro B, Girmenia C, Ossi C, Pan A, Candoni A, Nosari A, Riva M, Cattaneo C, Rossini F, Fianchi L, Caira M, Sanguinetti M, Gesu GP, Lombardi G, Vianelli N, Stanzani M, Mirone E, Pinsi G, Facchetti F, Manca N, Savi L, Mettimano M, Selva V, Caserta I, Scarpellini P, Morace G, D'Arminio Monforte A, Grossi P, Giudici D, Tortorano AM, Bonini A, Ricci L, Picardi M, Rossano F, Fanci R, Pecile P, Fumagalli L, Ferrari L, Capecchi PL, Romano C, Busca A, Barbui A, Garzia M, Minniti RR, Farina G, Montagna MT, Bruno F, Morelli O, Chierichini A, Placanica PM, Castagnola E, Bandettini R, Giordano S, Monastero R, Tosti ME, Rossi MR, Spedini P, Piane R, Nucci M, Pallavicini F, Bassetti M, Cristini F, LA Sorda M, Viviani M.

J Chemother. 2009 Jun;21(3):322-9.

PMID:
19567354
31.

Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR.

Varani S, Stanzani M, Paolucci M, Melchionda F, Castellani G, Nardi L, Landini MP, Baccarani M, Pession A, Sambri V.

J Infect. 2009 May;58(5):346-51. doi: 10.1016/j.jinf.2009.03.001. Epub 2009 Mar 13.

PMID:
19362374
32.

Identification of an invasive infection of R. oryzae in a haematological patient using a molecular technique.

Cavrini F, Stanzani M, Liguori G, Sambri V.

Mycoses. 2010 May;53(3):269-71. doi: 10.1111/j.1439-0507.2009.01689.x. Epub 2009 Mar 17.

PMID:
19302460
33.

Update on the treatment of disseminated fusariosis: Focus on voriconazole.

Stanzani M, Tumietto F, Vianelli N, Baccarani M.

Ther Clin Risk Manag. 2007 Dec;3(6):1165-73.

34.

LKM1-positive type 2 autoimmune hepatitis following allogenic hematopoietic stem-cell transplantation.

Granito A, Stanzani M, Muratori L, Bogdanos DP, Muratori P, Pappas G, Quarneti C, Lenzi M, Vergani D, Bianchi FB.

Am J Gastroenterol. 2008 May;103(5):1313-4. doi: 10.1111/j.1572-0241.2007.01782_7.x. No abstract available.

PMID:
18477361
35.

Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline.

Stanzani M, Tumietto F, Giannini MB, Bianchi G, Nanetti A, Vianelli N, Arpinati M, Giovannini M, Bonifazi F, Bandini G, Baccarani M.

J Med Microbiol. 2007 Dec;56(Pt 12):1692-5.

PMID:
18033842
36.

Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.

Orciuolo E, Stanzani M, Canestraro M, Galimberti S, Carulli G, Lewis R, Petrini M, Komanduri KV.

J Leukoc Biol. 2007 Oct;82(4):839-48. Epub 2007 Jul 11.

PMID:
17626149
37.

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

Zaja F, Bacigalupo A, Patriarca F, Stanzani M, Van Lint MT, Filì C, Scimè R, Milone G, Falda M, Vener C, Laszlo D, Alessandrino PE, Narni F, Sica S, Olivieri A, Sperotto A, Bosi A, Bonifazi F, Fanin R; GITMO (Gruppo Italiano Trapianto Midollo Osseo).

Bone Marrow Transplant. 2007 Aug;40(3):273-7. Epub 2007 Jun 4.

38.

Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.

Arpinati M, Chirumbolo G, Saunthararajah Y, Stanzani M, Bonifazi F, Bandini G, Baccarani M, Rondelli D.

Biol Blood Marrow Transplant. 2007 Feb;13(2):228-34.

39.

Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.

Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG.

Neurology. 2006 Oct 24;67(8):1458-60. Epub 2006 Sep 13.

40.

Effect on survival of the development of late-onset non-infectious pulmonary complications after stem cell transplantation.

Patriarca F, Skert C, Bonifazi F, Sperotto A, Fili C, Stanzani M, Zaja F, Cerno M, Geromin A, Bandini G, Baccarani M, Fanin R.

Haematologica. 2006 Sep;91(9):1268-72.

41.

Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B.

Stanzani M, Vianelli N, Bandini G, Paolini S, Arpinati M, Bonifazi F, Giannini B, Agostinelli C, Baccarani M, Ricci P.

J Infect. 2006 Dec;53(6):e243-6. Epub 2006 Apr 11.

PMID:
16584783
42.

In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study.

Bonifazi F, Bandini G, Stanzani M, Palandri F, Giannini B, Arpinati M, Rosti G, Baccarani M.

Bone Marrow Transplant. 2005 May;35(10):1025-6. No abstract available.

PMID:
15806130
43.

Umbilical-cord blood for transplantation in adults.

Bandini G, Bonifazi F, Stanzani M.

N Engl J Med. 2005 Mar 3;352(9):935-7; author reply 935-7. No abstract available.

PMID:
15751127
44.

Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.

Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KV.

Blood. 2005 Mar 15;105(6):2258-65. Epub 2004 Nov 16.

45.

Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.

Arpinati M, Chirumbolo G, Urbini B, Bonifazi F, Bandini G, Saunthararajah Y, Zagnoli A, Stanzani M, Falcioni S, Perrone G, Tura S, Baccarani M, Rondelli D.

Biol Blood Marrow Transplant. 2004 Feb;10(2):106-15.

46.

Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.

Urbini B, Arpinati M, Bonifazi F, Chirumbolo G, Falcioni S, Stanzani M, Bandini G, Motta MR, Perrone G, Giannini B, Tura S, Baccarani M, Rondelli D.

Exp Hematol. 2003 Oct;31(10):959-65.

PMID:
14550812
47.

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.

Stanzani M, Martins SL, Saliba RM, St John LS, Bryan S, Couriel D, McMannis J, Champlin RE, Molldrem JJ, Komanduri KV.

Blood. 2004 Feb 1;103(3):1140-6. Epub 2003 Aug 7.

48.

Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML.

Bonifazi F, Bandini G, Rondelli D, Falcioni S, Stanzani M, Bontadini A, Tazzari PL, Arpinati M, Giannini B, Conte R, Baccarani M.

Bone Marrow Transplant. 2003 Aug;32(3):237-42.

PMID:
12858193
49.

Monopharmacologic general anaesthesia with sevoflurane in paediatric patient with Prader-Willi syndrome.

Rinaldi S, Rizzo L, Di Filippo A, Secchi S, Paternoster G, La Torre MS, Pascente C, Stanzani MR.

Minerva Anestesiol. 2002 Oct;68(10):783-90. English, Italian.

50.

Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation.

Arpinati M, Chirumbolo G, Urbini B, Martelli V, Stanzani M, Falcioni S, Bonifazi F, Bandini G, Tura S, Baccarani M, Rondelli D.

Bone Marrow Transplant. 2002 Jun;29(11):887-91.

Supplemental Content

Loading ...
Support Center